News | August 24, 2008

Study Shows Starion Ligating Shears Good for Endoscopic Artery, Vein Harvesting

August 25, 2008 - Starion Instruments said a study recently presented at the 2008 Annual Scientific Meeting of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) found Starion’s Tissue Ligating Shears provides a safe and effective solution for endoscopic harvesting of the radial artery and saphenous vein. Minimally invasive vessel harvesting is an important technique for coronary artery bypass graft procedures. While devices are available for either radial artery or saphenous vein harvesting, access to a single system with which to perform both procedures has been limited. The study, “Safety and Efficacy of a Single System for Minimally Invasive Harvesting of Both Radial Artery and Saphenous Vein,” was led by Guido Gelpi, M.D. from the cardiovascular division of L. Sacco Hospital, University of Milan, Milan, Italy. Gelpi and his team assessed the safety and efficacy of a single system (Starion Tissue Ligating Shears and Datascope retractor and vessel extractor) with which to harvest both the radial artery and saphenous vein. Forty patients were prospectively randomized. The researchers endoscopically harvested radial arteries from 10 patients and saphenous veins from another 10 patients using the Starion/Datascope system. They also harvested radial arteries from 10 patients and saphenous veins from another 10 patients using conventional, open techniques. Besides the smaller incisions and higher patient satisfaction, the endoscopically harvested groups presented with no skin dehiscence. “Starion’s Tissue Ligating Shears coupled with Datascope’s retractor and dissector represent an ideal system for endoscopic harvesting of both the radial artery and saphenous vein,” said Dr. Gelpi. “This single, safe and effective system does not alter artery or vein vasoreactivity and shows good results in terms of efficiency and patient satisfaction.” For more information: www.starioninstruments.com

Related Content

Open Heart Surgery Outperforms Stents in Patients With Multivessel Disease
News | Cardiovascular Surgery | May 03, 2019
Coronary artery bypass grafting (CABG) surgery may be the best treatment option for most patients with more than one...
SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019
Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) for a design...
Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Overlay Init